Targeting Leukotrienes as a Therapeutic Strategy to Prevent Comorbidities Associated with Metabolic Stress-Reference-Cited by-同舟云学术

Targeting Leukotrienes as a Therapeutic Strategy to Prevent Comorbidities Associated with Metabolic Stress

Published:2020 Issue: Volume: Page:55-69
ISSN:0065-2598
Container-title:Druggable Lipid Signaling Pathways
language:
Short-container-title:

Author:

Ramalho Theresa,Pereira Nayara,Brandt Stephanie L.,Serezani C. Henrique

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-030-50621-6_4

Reference139 articles.

1. Harkavy J (1930) Spam-producing substance in the sputum of patiensts with bronchial asthma. Arch Intern Med 45:641

2. Kellaway C, Trethewie E (1940) The liberation of a slow-reacting smooth muscle-stimulating substance in anaphylaxis. Q J Exp Physiol Cogn Med Sci 30:121–145

3. Feldberg W, Kellaway CH (1938) Liberation of histamine and formation of lysocithin-like substances by cobra venom. J Physiol 94:187–226

4. Brocklehurst W (1960) The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J Physiol 151:416–435

5. Orange RP, Murphy RC, Karnovsky ML, Austen KF (1973) The physicochemical characteristics and purification of slow-reacting substance of anaphylaxis. J Immunol 110:760–770

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Soluble Epoxide Hydrolase Inhibitor, 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis;International Journal of Molecular Sciences;2021-04-28

2. Fatty acid handling in mammalian cells;Biochemistry of Lipids, Lipoproteins and Membranes;2021